Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berend J van der Wilk

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Journal of Thoracic Disease|June 18, 2025
Development and validation of a prognostic model for overall survival in pN0 esophageal cancer patients after neoadjuvant chemotherapy: a SEER database-based studyPengjie Yang, Ting Yang, Tianlai Liu, et al.
Journal of Gastrointestinal Oncology|July 11, 2024
Safety and short-term outcomes of esophagectomy after neoadjuvant immunotherapy combined with chemotherapy or chemoradiotherapy for locally advanced esophageal squamous cell cancer: analysis of two phase-II clinical trialsDijian Shen, Runzhe Chen, Qing Wu, et al.
Journal of Thoracic Disease|April 15, 2024
Comparisons of short-term outcomes between robot-assisted, video-assisted, and open esophagectomy for resectable esophageal cancer after neoadjuvant treatment: a retrospective studyZiheng Wu, Jiacong Liu, Lichen Zhang, et al.
Journal of Thoracic Disease|May 14, 2019
The optimal neoadjuvant treatment of locally advanced esophageal cancerBerend J van der Wilk, Ben M Eyck, Sjoerd M Lagarde, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 12, 2021
Lasting symptoms and long-term health-related quality of life after totally minimally invasive, hybrid and open Ivor Lewis esophagectomyBen M Eyck, Fredrik Klevebro, Berend J van der Wilk, et al.
European Journal of Medical Genetics|January 11, 2020
Development of esophageal squamous cell cancer in patients with FAMMM syndrome: Two clinical reportsBerend J van der Wilk, Bo J Noordman, Peggy N Atmodimedjo, et al.
Annals of Surgical Oncology|August 16, 2023
Characteristics Predicting Short-Term and Long-Term Health-Related Quality of Life in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy and EsophagectomyBerend J van der Wilk, Ben M Eyck, Bo J Noordman, et al.
Annals of Surgery|August 14, 2024
Prolonged Time to Surgery in Patients with Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal CancerHidde C G Overtoom, Ben M Eyck, Berend J van der Wilk, et al.
Journal of Oncology|January 17, 2022
Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer CellsMandy Gruijs, Rens Braster, Marije B Overdijk, et al.
Annals of Translational Medicine|September 17, 2021
Liquid biopsy in esophageal cancer: a case report of false-positive circulating tumor DNA detection due to clonal hematopoiesisJonathan Spoor, Ben M Eyck, Peggy N Atmodimedjo, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Journal of Thoracic Disease|June 18, 2025
Development and validation of a prognostic model for overall survival in pN0 esophageal cancer patients after neoadjuvant chemotherapy: a SEER database-based studyPengjie Yang, Ting Yang, Tianlai Liu, et al.
Journal of Gastrointestinal Oncology|July 11, 2024
Safety and short-term outcomes of esophagectomy after neoadjuvant immunotherapy combined with chemotherapy or chemoradiotherapy for locally advanced esophageal squamous cell cancer: analysis of two phase-II clinical trialsDijian Shen, Runzhe Chen, Qing Wu, et al.
Journal of Thoracic Disease|April 15, 2024
Comparisons of short-term outcomes between robot-assisted, video-assisted, and open esophagectomy for resectable esophageal cancer after neoadjuvant treatment: a retrospective studyZiheng Wu, Jiacong Liu, Lichen Zhang, et al.
Journal of Thoracic Disease|May 14, 2019
The optimal neoadjuvant treatment of locally advanced esophageal cancerBerend J van der Wilk, Ben M Eyck, Sjoerd M Lagarde, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 12, 2021
Lasting symptoms and long-term health-related quality of life after totally minimally invasive, hybrid and open Ivor Lewis esophagectomyBen M Eyck, Fredrik Klevebro, Berend J van der Wilk, et al.
European Journal of Medical Genetics|January 11, 2020
Development of esophageal squamous cell cancer in patients with FAMMM syndrome: Two clinical reportsBerend J van der Wilk, Bo J Noordman, Peggy N Atmodimedjo, et al.
Annals of Surgical Oncology|August 16, 2023
Characteristics Predicting Short-Term and Long-Term Health-Related Quality of Life in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy and EsophagectomyBerend J van der Wilk, Ben M Eyck, Bo J Noordman, et al.
Annals of Surgery|August 14, 2024
Prolonged Time to Surgery in Patients with Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal CancerHidde C G Overtoom, Ben M Eyck, Berend J van der Wilk, et al.
Journal of Oncology|January 17, 2022
Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer CellsMandy Gruijs, Rens Braster, Marije B Overdijk, et al.
Annals of Translational Medicine|September 17, 2021
Liquid biopsy in esophageal cancer: a case report of false-positive circulating tumor DNA detection due to clonal hematopoiesisJonathan Spoor, Ben M Eyck, Peggy N Atmodimedjo, et al.
Pageof 4